Skip to main content

Eazyplex Candida auris

Direct diagnosis from swabs, and culture confirmation, in 25 minutes!

"The number of reported C. auris cases in European countries has increased significantly since the last ECDC rapid risk assessment on C. auris in December 2016. There continues to be a need to raise awareness of C. auris in European healthcare facilities, so that they may adapt their laboratory testing strategies and implement enhanced infection prevention and control measures where necessary."
European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – first update, 23 April 2018. Stockholm: ECDC; 2018

The eazyplex® Candida auris is a qualitative in vitro diagnostic medical device for use in the detection of a specific nucleic acid sequence of Candida auris from skin or pharyngeal swabs, or yeast colonies via isothermal LAMP-method ("Loop-mediated isothermal AMPlification")

The intended purposes of the test includes:

  • Screening of asymptomatic patients via skin or pharyngeal swabs.
  • Aid to diagnosis of all kinds of patients via testing of yeast colonies.

Protective mechanisms to prevent the use of false results:

  • Performance of "inhibition control" with each sample prevents the use of false negative test results, due to the inhibition of the amplification reaction whilst simultaneously serving as reagent control. 
  • The test result is only displayed if the inhibition control is valid. 
  • As required, a test strip can be processed as negative/ contamination control by testing RALF without addition of sample material. In this case, only the inhibition control is allowed to create a positive signal.

 

Specifications

  • Quantity: 24
  • Product Code: AM-E7854